These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2303126)

  • 21. Endothelial injury following experimental subarachnoid hemorrhage in rats: effects on brain blood flow.
    Clower BR; Yamamoto Y; Cain L; Haines DE; Smith RR
    Anat Rec; 1994 Sep; 240(1):104-14. PubMed ID: 7810907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic changes in cerebral arteries after subarachnoid hemorrhage.
    Mayberg MR; Okada T; Bark DH
    Neurosurg Clin N Am; 1990 Apr; 1(2):417-32. PubMed ID: 2136152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    Kwan AL; Lin CL; Yanamoto H; Howng SL; Kassell NF; Lee KS
    Neurosurgery; 1998 Feb; 42(2):347-50; discussion 350-1. PubMed ID: 9482186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two indices of functional damage of the artery wall parallel the time course of irreversible narrowing in experimental vasospasm in the rabbit.
    Vorkapic P; Bevan JA; Bevan RD
    Blood Vessels; 1991; 28(1-3):179-82. PubMed ID: 2001468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is vasospasm related to proliferative arteriopathy?
    Pluta RM; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
    J Neurosurg; 1992 Nov; 77(5):740-8. PubMed ID: 1403117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage.
    Kim P; Sundt TM; Vanhoutte PM
    J Neurosurg; 1989 Sep; 71(3):430-6. PubMed ID: 2769393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm.
    Seifert V; Stolke D; Kunz U; Resch K
    Neurosurgery; 1988 Sep; 23(3):313-21. PubMed ID: 3147407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit.
    Arthur AS; Fergus AH; Lanzino G; Mathys J; Kassell NF; Lee KS
    Neurosurgery; 1997 Dec; 41(6):1385-91; discussion 1391-2. PubMed ID: 9402590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etiology and treatment of vasospasm following subarachnoid hemorrhage.
    Nonaka T; Watanabe S; Chigasaki H; Miyaoka M; Ishii S
    Neurol Med Chir (Tokyo); 1979 Jan; 19(1):53-60. PubMed ID: 84356
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebral artery spasm: histological changes in necropsies of cases of subarachnoid hemorrhage.
    Schianchi PM; Hughes JT
    Adv Neurol; 1978; 20():521-34. PubMed ID: 676916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ultrastructural changes in cerebral arterial wall and cerebral vasopasm--an experimental study (author's transl)].
    Tanabe Y; Kagawa Y; Takada M; Yamada H; Sakata K
    No Shinkei Geka; 1978 Jul; 6(7):663-72. PubMed ID: 683448
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats.
    Ram Z; Sadeh M; Shacked I; Sahar A; Hadani M
    Stroke; 1991 Jul; 22(7):922-7. PubMed ID: 1853412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
    Gavras H; Andrews P; Papadakis N
    J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
    Hara H; Nosko M; Weir B
    J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries.
    Delgado TJ; Brismar J; Svendgaard NA
    Stroke; 1985; 16(4):595-602. PubMed ID: 4024174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronological changes of arterial diameter, cGMP, and protein kinase C in the development of vasospasm.
    Nishizawa S; Yamamoto S; Yokoyama T; Ryu H; Uemura K
    Stroke; 1995 Oct; 26(10):1916-20; discussion 1920-1. PubMed ID: 7570748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The study of occurrence mechanism in acute and chronic cerebral vasospasm].
    Jiang K
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):344-6, 383. PubMed ID: 1304997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of cerebral vasospasm.
    Alksne JF; Branson PJ
    Neurol Res; 1980; 2(3-4):273-82. PubMed ID: 6111035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.